PON1 and metabolic dysfunction-associated steatotic liver disease: A study in Romania included 81 patients with MASLD with elevated transaminase levels diagnosed by abdominal ultrasound and 81 healthy controls and demonstrated that patients with MASLD had lower serum PON1 levels and that the rs854560 mutation was a risk factor for MASLD (OR:3.44, p = 0.04).31